McMaster College researchers Hong Han and Sheila Singh have been named Canada Analysis Chairs.
Two members of McMaster’s College of Well being Sciences and the Centre for Discovery in Most cancers Analysis (CDCR) have been named Canada Analysis Chairs (CRCs).
Hong Han, an assistant professor with the Division of Biochemistry and Biomedical Sciences, has been awarded a Tier 2 Canada Analysis Chair in Most cancers Methods Biology. Sheila Singh, a professor with the Division of Surgical procedure and director of the CDCR, had her Tier 1 Canada Analysis Chair in Human Most cancers Stem Cell Biology renewed.
There are two tiers of CRCs which acknowledge completed and rising leaders of their respective fields. Tier 1 chairs are held for seven years and renewable as soon as with an funding of $200,000 yearly; Tier 2 chairs are held for 5 years and are renewable as soon as with an funding of $100,000 yearly, with a further $20,000 annual stipend for first-term chairs.
“Congratulations to Dr. Hong Han and Dr. Sheila Singh on being awarded prestigious Canada Analysis Chairs. This exceptional achievement not solely underscores their distinctive contributions to their respective fields, but additionally enhances McMaster College’s dedication to analysis excellence and innovation,” says Paul O’Byrne, dean and vice-president of the College of Well being Sciences.
Han is a brand new Tier 2 Analysis Chair in Most cancers Methods Biology. She is a principal investigator with the Centre for Discovery in Most cancers Analysis and an assistant professor with the Division of Biochemistry and Biomedical Sciences at McMaster. The analysis of the Han Lab has centered on high-throughput investigation of most cancers biology, particularly different splicing and coordinated multilayer gene rules that influence most cancers development, remedy response and relapse. Han’s work additionally goals to uncover new RNA-multimodal therapeutic targets via the examine of treatment-resistant cancers, similar to glioblastoma, an aggressive type of mind most cancers.
“I’m honoured to be acknowledged as a Canada Analysis Chair. It’s a privilege to work with an extremely proficient group and be a part of the very supportive group at McMaster. My lab works on the interface of most cancers biology, multilayer gene regulation, and revolutionary high-throughput applied sciences. Along with colleagues and leaders from associated fields, we sit up for creating methods biology and multi-omics platforms that broadly profit biomedical analysis and support in discovering new biomarkers and therapeutics,” Han says.
Singh is director of the Centre for Discovery in Most cancers Analysis and along with her function as a professor of surgical procedure, she is an affiliate member with the Division of Biochemistry and Biomedical Sciences. Singh noticed her Tier 1 Canada Analysis Chair in Human Most cancers Stem Cell Biology renewed.
Singh’s analysis is groundbreaking in most cancers stem cell biology. She recognized mind tumor-initiating cells, that are key to the event and unfold of mind tumors like glioblastomas and medulloblastomas.
“Along with working my very own primary and translational mind most cancers analysis program and advancing lots of our discoveries into the event of recent therapies for sufferers with glioblastoma, medulloblastoma and mind metastases, I wish to work with different leaders in most cancers analysis and most cancers care throughout Hamilton to contribute to creating a complete city-wide most cancers imaginative and prescient, whereby we translate our primary discoveries into new therapies that may be superior via scientific trials and in the end profit sufferers within the larger Hamilton area and past.”
